Tuesday - September 29, 2026
California firm licenses 'potent' anti-measles antibodies from Vanderbilt Health for development, clinical testing
September 28, 2026
NASHVILLE, Tennessee, Sept. 28 -- Vanderbilt University Medical Center posted the following news release:

* * *

California firm licenses 'potent' anti-measles antibodies from Vanderbilt Health for development, clinical testing

*

Vanderbilt Health researchers and colleagues have isolated human monoclonal antibodies from previously infected individuals that potently neutralized the measles virus in the laboratory and strongly inhibited . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products